Frontiers in Neuroinformatics最新文献

Although the anatomical arrangement of brain regions and the functional structures within them are similar across individuals, the representation of neural information, such as recorded brain activity, varies among individuals owing to various factors. Therefore, appropriate conversion and translation of brain information is essential when decoding neural information using a model trained using another person's data or to achieving brain-to-brain communication. We propose a brain representation transfer method that involves transforming a data representation obtained from one person's brain into that obtained from another person's brain, without relying on corresponding label information between the transferred datasets. We defined the requirements to enable such brain representation transfer and developed an algorithm that distills the assumption of common similarity structure across the brain datasets into a rotational and reflectional transformation across low-dimensional hyperspheres using encoders for non-linear dimensional reduction. We first validated our proposed method using data from artificial neural networks as substitute neural activity and examining various experimental factors. We then evaluated the applicability of our method to real brain activity using functional magnetic resonance imaging response data acquired from human participants. The results of these validation experiments showed that our method successfully performed representation transfer and achieved transformations in some cases that were similar to those obtained when using corresponding label information. Additionally, we reconstructed images from individuals' data without training personalized decoders by performing brain representation transfer. The results suggest that our unsupervised transfer method is useful for the reapplication of existing models personalized to specific participants and datasets to decode brain information from other individuals. Our findings also serve as a proof of concept for the methodology, enabling the exchange of the latent properties of neural information representing individuals' sensations.

Brain tumor classification is a critical task in medical imaging, as accurate diagnosis directly influences treatment planning and patient outcomes. Traditional methods often fall short in achieving the required precision due to the complex and heterogeneous nature of brain tumors. In this study, we propose an innovative approach to brain tumor multi-classification by leveraging an ensemble learning method that combines advanced deep learning models with an optimal weighting strategy. Our methodology integrates Vision Transformers (ViT) and EfficientNet-V2 models, both renowned for their powerful feature extraction capabilities in medical imaging. This model enhances the feature extraction step by capturing both global and local features, thanks to the combination of different deep learning models with the ViT model. These models are then combined using a weighted ensemble approach, where each model's prediction is assigned a weight. To optimize these weights, we employ a genetic algorithm, which iteratively selects the best weight combinations to maximize classification accuracy. We trained and validated our ensemble model using a well-curated dataset comprising labeled brain MRI images. The model's performance was benchmarked against standalone ViT and EfficientNet-V2 models, as well as other traditional classifiers. The ensemble approach achieved a notable improvement in classification accuracy, precision, recall, and F1-score compared to individual models. Specifically, our model attained an accuracy rate of 95%, significantly outperforming existing methods. This study underscores the potential of combining advanced deep learning models with a genetic algorithm-optimized weighting strategy to tackle complex medical classification tasks. The enhanced diagnostic precision offered by our ensemble model can lead to better-informed clinical decisions, ultimately improving patient outcomes. Furthermore, our approach can be generalized to other medical imaging classification problems, paving the way for broader applications of AI in healthcare. This advancement in brain tumor classification contributes valuable insights to the field of medical AI, supporting the ongoing efforts to integrate advanced computational tools in clinical practice.

We introduce an open-source Python package for the analysis of large-scale electrophysiological data, named SyNCoPy, which stands for Systems Neuroscience Computing in Python. The package includes signal processing analyses across time (e.g., time-lock analysis), frequency (e.g., power spectrum), and connectivity (e.g., coherence) domains. It enables user-friendly data analysis on both laptop-based and high-performance computing systems. SyNCoPy is designed to facilitate trial-parallel workflows (parallel processing of trials), making it an ideal tool for large-scale analysis of electrophysiological data. Based on parallel processing of trials, the software can support very large-scale datasets via innovative out-of-core computation techniques. It also provides seamless interoperability with other standard software packages through a range of file format importers and exporters and open file formats. The naming of the user functions closely follows the well-established FieldTrip framework, which is an open-source MATLAB toolbox for advanced analysis of electrophysiological data.

Elderly and individuals with disabilities can greatly benefit from human activity recognition (HAR) systems, which have recently advanced significantly due to the integration of the Internet of Things (IoT) and artificial intelligence (AI). The blending of IoT and AI methodologies into HAR systems has the potential to enable these populations to lead more autonomous and comfortable lives. HAR systems are equipped with various sensors, including motion capture sensors, microcontrollers, and transceivers, which supply data to assorted AI and machine learning (ML) algorithms for subsequent analyses. Despite the substantial advantages of this integration, current frameworks encounter significant challenges related to computational overhead, which arises from the complexity of AI and ML algorithms. This article introduces a novel ensemble of gated recurrent networks (GRN) and deep extreme feedforward neural networks (DEFNN), with hyperparameters optimized through the artificial water drop optimization (AWDO) algorithm. This framework leverages GRN for effective feature extraction, subsequently utilized by DEFNN for accurately classifying HAR data. Additionally, AWDO is employed within DEFNN to adjust hyperparameters, thereby mitigating computational overhead and enhancing detection efficiency. Extensive experiments were conducted to verify the proposed methodology using real-time datasets gathered from IoT testbeds, which employ NodeMCU units interfaced with Wi-Fi transceivers. The framework's efficiency was assessed using several metrics: accuracy at 99.5%, precision at 98%, recall at 97%, specificity at 98%, and F1-score of 98.2%. These results then were benchmarked against other contemporary deep learning (DL)-based HAR systems. The experimental outcomes indicate that our model achieves near-perfect accuracy, surpassing alternative learning-based HAR systems. Moreover, our model demonstrates reduced computational demands compared to preceding algorithms, suggesting that the proposed framework may offer superior efficacy and compatibility for deployment in HAR systems designed for elderly or individuals with disabilities.

Introduction: Over the past few decades, numerous researchers have explored the application of machine learning for assessing children's neurological development. Developmental changes in the brain could be utilized to gauge the alignment of its maturation status with the child's chronological age. AI is trained to analyze changes in different modalities and estimate the brain age of subjects. Disparities between the predicted and chronological age can be viewed as a biomarker for a pathological condition. This literature review aims to illuminate research studies that have employed AI to predict children's brain age.

Methods: The inclusion criteria for this study were predicting brain age via AI in healthy children up to 12 years. The search term was centered around the keywords "pediatric," "artificial intelligence," and "brain age" and was utilized in PubMed and IEEEXplore. The selected literature was then examined for information on data acquisition methods, the age range of the study population, pre-processing, methods and AI techniques utilized, the quality of the respective techniques, model explanation, and clinical applications.

Results: Fifty one publications from 2012 to 2024 were included in the analysis. The primary modality of data acquisition was MRI, followed by EEG. Structural and functional MRI-based studies commonly used publicly available datasets, while EEG-based studies typically relied on self-recruitment. Many studies utilized pre-processing pipelines provided by toolkit suites, particularly in MRI-based research. The most frequently used model type was kernel-based learning algorithms, followed by convolutional neural networks. Overall, prediction accuracy may improve when multiple acquisition modalities are used, but comparing studies is challenging. In EEG, the prediction error decreases as the number of electrodes increases. Approximately one-third of the studies used explainable artificial intelligence methods to explain the model and chosen parameters. However, there is a significant clinical translation gap as no study has tested their model in a clinical routine setting.

Discussion: Further research should test on external datasets and include low-quality routine images for MRI. T2-weighted MRI was underrepresented. Furthermore, different kernel types should be compared on the same dataset. Implementing modern model architectures, such as convolutional neural networks, should be the next step in EEG-based research studies.

Alzheimer's disease (AD) is a progressive neurological disorder characterized by the gradual deterioration of cognitive functions, leading to dementia and significantly impacting the quality of life for millions of people worldwide. Early and accurate diagnosis is crucial for the effective management and treatment of this debilitating condition. This study introduces a novel framework based on Spectral Graph Convolutional Neural Networks (SGCNN) for diagnosing AD and categorizing multiple diseases through the analysis of functional changes in brain structures captured via magnetic resonance imaging (MRI). To assess the effectiveness of our approach, we systematically analyze structural modifications to the SGCNN model through comprehensive ablation studies. The performance of various Convolutional Neural Networks (CNNs) is also evaluated, including SGCNN variants, Base CNN, Lean CNN, and Deep CNN. We begin with the original SGCNN model, which serves as our baseline and achieves a commendable classification accuracy of 93%. In our investigation, we perform two distinct ablation studies on the SGCNN model to examine how specific structural changes impact its performance. The results reveal that Ablation Model 1 significantly enhances accuracy, achieving an impressive 95%, while Ablation Model 2 maintains the baseline accuracy of 93%. Additionally, the Base CNN model demonstrates strong performance with a classification accuracy of 93%, whereas both the Lean CNN and Deep CNN models achieve 94% accuracy, indicating their competitive capabilities. To validate the models' effectiveness, we utilize multiple evaluation metrics, including accuracy, precision, recall, and F1-score, ensuring a thorough assessment of their performance. Our findings underscore that Ablation Model 1 (SGCNN Model 1) delivers the highest predictive accuracy among the tested models, highlighting its potential as a robust approach for Alzheimer's image classification. Ultimately, this research aims to facilitate early diagnosis and treatment of AD, contributing to improved patient outcomes and advancing the field of neurodegenerative disease diagnosis.